Transcranial Sonography of the Substantia Nigra: Digital Image Analysis

References

1. 1.↵
   2. Fearnley JM,
   3. Lees AJ

   . Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283–301

   Abstract/FREE Full Text
2. 2.↵
   2. Lees AJ

   . When did Ray Kennedy's Parkinson's disease begin? Mov Disord 1992;7:110–16

   PubMedWeb of Science
3. 3.↵
   2. Vingerhoets FJ,
   3. Snow BJ,
   4. Lee CS, et al

   . Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 1994;36:759–64

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Hilker R,
   3. Schweitzer K,
   4. Coburger S, et al

   . Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 2005;62:378–82

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Poewe W

   . The need for neuroprotective therapies in Parkinson's disease: a clinical perspective. Neurology 2006;66:S2–9

   CrossRef
6. 6.↵
   2. Berg D,
   3. Siefker C,
   4. Becker G

   . Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684–89

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Walter U,
   3. Wittstock M,
   4. Benecke R, et al

   . Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002;109:191–96

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Berg D,
   3. Becker G,
   4. Zieler B, et al

   . Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026–31

   CrossRef
9. 9.↵
   2. Berg D,
   3. Merz B,
   4. Reiners K, et al

   . Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005;20:383–85

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Gaenslen A,
    3. Unmuth B,
    4. Godau J, et al

    . The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008;7:417–24

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Berg D,
    3. Jabs B,
    4. Merschdorf U, et al

    . Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001;50:463–67

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Bogdahn U,
    3. Becker G,
    4. Schlachetzki F

    . Echoenhancers and Transcranial Color Duplex Sonography. Berlin: Blackwell Science; 1998
13. 13.↵
    2. Kollár J,
    3. Schulte-Altedorneburg G,
    4. Sikula J, et al

    . Image quality of the temporal bone window examined by transcranial Doppler sonography and correlation with postmortem computed tomography measurements. Cerebrovasc Dis 2004;17:61–65

    CrossRefPubMed
14. 14.↵
    2. Školoudík D,
    3. Fadrná T,
    4. Bártová P, et al

    . Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol 2007;33:1347–52

    CrossRefPubMed
15. 15.↵
    2. Blahuta J,
    3. Soukup T,
    4. Čermák P

    . Image processing of medical diagnostic neurosonographical images in MATLAB. In: Recent Researches in Computer Science. Proceedings of the 15th World Scientific and Engineering Academy and Society Circuits, Systems, Communications, and Computers Multiconference, Corfu Island, Greece. July 15–17, 2011:85–90
16. 16.↵
    2. Blahuta J,
    3. Soukup T,
    4. Jelínková M, et al

    . A new program for highly reproducible automatic evaluation of the substantia nigra from transcranial sonographic images. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013 Apr 22. [Epub ahead of print]
17. 17.↵
    2. Daniel SE,
    3. Lees AJ

    . Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993;39:165–72

    PubMed
18. 18.↵
    2. Berg D,
    3. Godau J,
    4. Walter U

    . Transcranial sonography in movement disorders. Lancet Neurol 2008;7:1044–55

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Ressner P,
    3. Skoloudik D,
    4. Hlustik P, et al

    . Echogenicity of substantia nigra in Parkinson's disease: pilot study. J Neuroimaging 2007;17:164–67

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Schreiber J,
    3. Sojka E,
    4. Licev L, et al

    . A new method for the detection of brain stem in transcranial ultrasound images. In: Proceedings of The International Joint Conference on Biomedical Engineering Systems and Technologies. Funchal, Madeira, Portugal. January 28–31, 2008;2:478–83
21. 21.↵
    2. Kier C,
    3. Cyrus C,
    4. Seidel G, et al

    . Segmenting the substantia nigra in ultrasound images for early diagnosis of Parkinson s disease. Int J Comput Assist Radiol Surg 2007;2(suppl 1):S83–85
22. 22.↵
    2. Sakalauskas A,
    3. Lukoševičius A,
    4. Laučkaitė K, et al

    . Automated segmentation of transcranial sonographic images in the diagnostics of Parkinson's disease. Ultrasonics 2013;53:111–21

    CrossRefPubMed
23. 23.↵
    2. van de Loo S,
    3. Walter U,
    4. Behnke S, et al

    . Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:1087–92

    Abstract/FREE Full Text
24. 24.↵
    2. Walter U,
    3. Dressler D,
    4. Probst T, et al

    . Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007;64:1635–40

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Walter U,
    3. Hoeppner J,
    4. Prudente-Morrissey L, et al

    . Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007;130:1799–807

    Abstract/FREE Full Text
26. 26.↵
    2. Berg D,
    3. Roggendorf W,
    4. Schröder U, et al

    . Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999–1005

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Becker G,
    3. Berg D

    . Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001;16:23–32

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Prestel J,
    3. Schweitzer KJ,
    4. Hofer A, et al

    . Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord 2006;21:1763–65

    CrossRefPubMed
29. 29.↵
    2. Berg D,
    3. Supprian T,
    4. Hofmann E, et al

    . Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999;246:1186–93

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Berg D,
    3. Hochstrasser H,
    4. Schweitzer KJ, et al

    . Disturbance of iron metabolism in Parkinson's disease: ultrasonography as a biomarker. Neurotox Res 2006;9:1–13

    CrossRefPubMed
31. 31.↵
    2. Zecca L,
    3. Berg D,
    4. Arzberger T, et al

    . In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005;20:1278–85

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Ruprecht-Dörfler P,
    3. Berg D,
    4. Tucha O, et al

    . Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003;18:416–22

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Školoudík D,
    3. Walter U

    . Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol 2010;90:7–34

    CrossRefPubMed
34. 34.↵
    2. Laganá MM,
    3. Forzoni L,
    4. Viotti S, et al

    . Assessment of the cerebral venous system from the transcondylar ultrasound window using virtual navigator technology and MRI. In: Proceedings of 33rd Annual International Conference of the Institute of Electrical and Electronics Engineers Engineering in Medicine and Biology Society, Boston, Massachusetts. August 30–September 3, 2011:579–82
35. 35.↵
    2. Školoudík D,
    3. Walter U

    . Sonographic Brain Atlas. Opava: REKESh Comp; 2013